StocksBluebird Bio IncBLUE

BLUE

Bluebird Bio Inc

27.73 -0.39 (-1.39%)
Delayed Prices By NASDAQ, in USD Market Open
Trade
S
27.73
B
27.92

Overview

Prev Close28.12
Day's Range27.62 - 27.99
52 Week Range24.20 - 72.37
Average Volume (3m)2.37M
1-Year Return-49.98%
Beta1.1486
Market Cap1.89B
P/E Ratio
Revenue250.73M
EPS-9.9501
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.710/11/202022/01/202106/04/202130.0035.0040.0045.0050.0055.0060.00
Chart times in UTC
Industry Biotechnology
CEO Nick Leschly, MBA
Employees 1,213

FINANCIAL SUMMARY

For the quarter ended 30/9/2020, Bluebird Bio Inc's revenues decreased by 90.31% and amounted to 19.27M. Net income decreased by 807.27% to -194.75M. Net assets decreased by 9.45% to 1.52B and EPS decreased from -0.36 to -2.94.
BLUE's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
90.13%
Net Profit Margin
-1,652.17%
Operating Margin
-251.07%
Return On Investment
-33.52%
12/19
03/20
06/20
09/20
Total Revenue
10M
21.86M
198.89M
19.27M
Gross Profit
3.87M
15.96M
192.79M
13.01M
Operating Income
-229.1M
N/A
-27.6M
-190.52M
Net Income
-223.35M
-202.61M
-21.47M
-194.75M